Literature DB >> 2417615

A new method for studying epidermalization in vitro.

B Coulomb, P Saiag, E Bell, F Breitburd, C Lebreton, M Heslan, L Dubertret.   

Abstract

A new method for studying epidermalization in vitro is described. It consists of inserting a punch biopsy that serves as a source of epidermis into dermal equivalent freshly made up, with fibroblasts mixed in a collagen matrix. Fibroblasts cling to collagen fibrils and contract the matrix, leading in 3 days to a resistant dermal equivalent holding the punch biopsy firmly in place. At day 5, a culture medium favouring epidermal growth was used and a fringe of a new epidermis appeared around the punch, the area of which grew linearly with time. This new epidermis showed a pattern of differentiation similar to epidermis in vivo, with cuboidal basal cells, keratohyalin granules, membrane coating granules and the expression of the 65-67 kd keratin subset. The method seems to combine the advantages of the explant technique and of classical keratinocyte cultures, providing the researcher with a large quantity of differentiated epidermis, the pharmacologist with simple and quantitative system in which to study modifications of growth and differentiation of epidermis, and the plastic surgeon with a possible material for skin grafting.

Mesh:

Substances:

Year:  1986        PMID: 2417615     DOI: 10.1111/j.1365-2133.1986.tb02783.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

Review 1.  Pigmented human skin equivalent--as a model of the mechanisms of control of cell-cell and cell-matrix interactions.

Authors:  K Nakazawa; M Kalassy; F Sahuc; C Collombel; O Damour
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

2.  Influence of initial collagen and cellular concentrations on the final surface area of dermal and skin equivalents: a Box-Behnken analysis.

Authors:  P Rompré; F A Auger; L Germain; V Bouvard; C A López Valle; J Thibault; A Le Duy
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

3.  Effects of amiprilose hydrochloride on the components of human skin equivalents.

Authors:  J C Hevelone; S D Dimitrijevich; R W Gracy
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

4.  Ultrastructural and immunohistochemical characterization of basal cells in three-dimensional culture models of the skin.

Authors:  Y Horiguchi; T Maruguchi; Y Maruguchi; S Suzuki; J D Fine; I M Leigh; T Yoshiki; M Ueda; K I Toda; N Isshiki
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Characterization of a new in vitro model for studies of reepithelialization in human partial thickness wounds.

Authors:  K Jansson; G Kratz; A Haegerstrand
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-10       Impact factor: 2.416

6.  Study of basement membrane formation in dermal-epidermal recombinants in vitro.

Authors:  A Chamson; N Germain; A Claudy; C Perier; J Frey
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Reconstructed human epidermis: absence of Langerhans cells and failure to stimulate allogeneic lymphocytes in vitro.

Authors:  M Bagot; B Bertaux; M Heslan; B Coulomb; L Dubertret
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

8.  Recessive epidermolysis bullosa simplex phenotype reproduced in vitro: ablation of keratin 14 is partially compensated by keratin 17.

Authors:  Abdoelwaheb El Ghalbzouri; Marcel Jonkman; Johanna Kempenaar; Maria Ponec
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  Epidermal growth in the skin equivalent.

Authors:  J Fransson; H Hammar
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  Proliferation and interferon-gamma receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model.

Authors:  J Fransson; A Emilson; A Scheynius; H Hammar
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.